Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2005
12/29/2005CA2568907A1 8-carbyl substituted cyclic adenosine-3'-5'-monophosphorothiolate compounds as camp modulators
12/29/2005CA2568902A1 Use of alpha-ketoglutarate and related compounds for lowering plasma lipids
12/29/2005CA2568756A1 Substituted quinazolones as anti-cancer agents
12/29/2005CA2568539A1 Small molecules for treatment of hypercholesterolemia and related diseases
12/29/2005CA2568394A1 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases
12/29/2005CA2568388A1 Preparation of macromolecular conjugates by four-component condensation reaction
12/29/2005CA2568379A1 C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
12/29/2005CA2567684A1 Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase
12/29/2005CA2567683A1 Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase
12/29/2005CA2567636A1 Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof
12/29/2005CA2566155A1 1-aza-bicyclo[3.3.1]nonanes
12/29/2005CA2565966A1 Lewis acid mediated synthesis of cyclic esters
12/29/2005CA2565342A1 Topical application of marine oils to foods
12/29/2005CA2550004A1 A lock solution for medical devices
12/28/2005EP1610341A2 Magnetic random access memory array with coupled soft magnetic adjacent layer
12/28/2005EP1609864A2 Use of neuronal apoptosis inhibitor protein (NAIP)
12/28/2005EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/28/2005EP1609852A1 Bifidobacteria and preparations containing them
12/28/2005EP1609799A1 Heteroaryl 5-thio-beta-d-glucopyranoside derivatives and remedies for diabetes containing the same
12/28/2005EP1609798A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
12/28/2005EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/28/2005EP1609789A1 Ureido-pyrazole derivatives and their use as kinase inhibitors
12/28/2005EP1609788A1 Novel crystal of fluorobenzamide derivative
12/28/2005EP1609785A1 C-glycoside derivatives and salts thereof
12/28/2005EP1609783A1 Marine compounds with calcium channel blocking properties for Alzheimer's disease treatment
12/28/2005EP1609781A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine
12/28/2005EP1609780A1 Remedy for diabetes
12/28/2005EP1609505A1 Uses of fluorinated triazoles for treaing pain and affective or attention disorders
12/28/2005EP1609504A1 T-type calcium channel blockers
12/28/2005EP1609494A1 Heparin barrier coating for controlled drug release
12/28/2005EP1609484A1 Cancer treatment with endothelin receptor antagonists
12/28/2005EP1609482A1 Drug for treating hemophilia and method of treating hemophilia using the same
12/28/2005EP1609481A1 Injectable pharmaceutical compositions comprising sodium diclofenac, beta-cyclodextrin and a polysorbate
12/28/2005EP1609479A1 Tumorigenesis inhibitor
12/28/2005EP1609477A1 Irrigation solution and use thereof for the perioperative inhibition of pain/inflammation and/or spasm at a vascular structure
12/28/2005EP1609473A1 Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria
12/28/2005EP1609472A1 Therapeutic agent for hemorrhoidal disease
12/28/2005EP1609471A1 Remedy and/or preventive for lung diseases
12/28/2005EP1609470A1 Nasal delivery of apomorphine
12/28/2005EP1609469A2 Compositions and methods for stimulating bone growth
12/28/2005EP1609468A2 A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis
12/28/2005EP1609467A1 Compositions for treating diseases associated with glycosaminoglycan-associated molecular interactions
12/28/2005EP1609466A1 Pharmaceutical compositions and uses thereof in the preparation of a medicament and/or food compostion for the treatment of overweight and/or correlated symptoms in humans and mammalian as well as process of preparation
12/28/2005EP1609465A1 Ophthalmic drug delivery system using polymer micell
12/28/2005EP1609462A1 Cosmetic or dermatological preparation comprising a nutrient medium phase
12/28/2005EP1609375A1 Glycine-containing food and use thereof
12/28/2005EP1609362A2 Non-systemic control of parasites
12/28/2005EP1608767A2 Optimized expression of hpv 31 l1 in yeast
12/28/2005EP1608755A2 Tak1-mediated inhibition of osteogenesis
12/28/2005EP1608735A2 Irna conjugates
12/28/2005EP1608733A2 Modified polynucleotides for use in rna interference
12/28/2005EP1608688A2 Branched water-soluble polymers and their conjugates
12/28/2005EP1608671A1 Oestrogen derivatives as inhibitors of steroid sulphatase
12/28/2005EP1608664A1 Non-cross-linking pyrrolo (2,1-c] (1,4]benzodiazepines as potential antitumour agents and process thereof
12/28/2005EP1608663A1 Pyrrolo (2,1-c)(1,4) benzodiazepines dimers as antitumour agents and process thereof
12/28/2005EP1608662A1 Guanidine derivatives and use thereof as neuropeptide ff receptor antagonists
12/28/2005EP1608661A2 Process for the preparaton of 7-(p-hydroxyphenylglycylamido)cephem compounds
12/28/2005EP1608656A2 Imidazotriazine compounds
12/28/2005EP1608654A2 8-SUBSTITUTED-6, 7, 8,9-TETRAHY9DROPYRIMIDO (1,2- a) PYRIMIDIN-4-ONE DERIVATIVES
12/28/2005EP1608653A1 SUBSTITUTED 8-PERFLUOROALKYL-6,7,8,9-TETRAHYDROPYRIMIDO (1,2- a) PYRIMIDIN-4-ONE DERIVATIVES
12/28/2005EP1608652A1 Pyrazolopyrimidine compounds and their use in medicine
12/28/2005EP1608651A1 Protein kinase inhibitors
12/28/2005EP1608650A1 Pyrene-linked pyrrolo(2,1-c)(1,4)benzodiazepine derivatives useful as anticancer agents
12/28/2005EP1608648A1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
12/28/2005EP1608646A1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products
12/28/2005EP1608645A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses
12/28/2005EP1608639A2 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
12/28/2005EP1608634A2 Methods for isolating crystalline form i of 5-azacytidine
12/28/2005EP1608632A1 Quinazolines useful as modulators of ion channels
12/28/2005EP1608631A2 Bi-cyclic pyrimidine inhibitors of tgf beta
12/28/2005EP1608628A2 Histone deacetylase inhibitors
12/28/2005EP1608627A2 Bicyclic anilide spirohydantoin cgrp receptor antagonists
12/28/2005EP1608626A1 Migrastatin analog compositions and uses thereof
12/28/2005EP1608625A1 Acutumine and acutumine compounds, synthesis and use
12/28/2005EP1608623A1 Metal ion chelators and therapeutic use thereof
12/28/2005EP1608622A2 Biaryl substituted 6-membered heterocyles as sodium channel blockers
12/28/2005EP1608407A2 Dispersible formulation of an anti-inflammatory agent
12/28/2005EP1608405A2 Nitric oxide in treatment of inflammation
12/28/2005EP1608404A2 Methods and means to suppress symptons of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18)
12/28/2005EP1608403A2 Immunostimulatory nucleic acid oil-in-water formulations for topical application
12/28/2005EP1608400A1 Elevation of adenosine level by cytokine-induced expression of cd73
12/28/2005EP1608391A2 Composition for inducing of immunotolerance
12/28/2005EP1608385A2 Therapeutic compositions
12/28/2005EP1608381A2 Novel therapeutic application for a composition
12/28/2005EP1608380A2 Polymeric drug agents for the treatment of fibrotic disorders
12/28/2005EP1608379A1 Compositions for treating angina
12/28/2005EP1608378A1 Prostaglandin compositions and their use for the treatment of vasospasm
12/28/2005EP1608377A2 Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
12/28/2005EP1608376A2 ACTIVATION SPECIFIC INHIBITORS OF NF-kB AND METHOD OF TREATING INFLAMMATORY PROCESSES IN CARDIO-VASCULAR DISEASES
12/28/2005EP1608375A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
12/28/2005EP1608374A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/28/2005EP1608373A2 Tie-2 modulators and methods of use
12/28/2005EP1608372A2 Compositions containing fentanyl
12/28/2005EP1608371A1 Process for the preparation of donepezil and derivatives thereof
12/28/2005EP1608370A1 Use of cuminum cyminum extract and piperine for potention of bioeffiacy of anti infectives
12/28/2005EP1608369A2 Use of organic compounds for immunopotentiation
12/28/2005EP1608368A1 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and ummunologically-mediated diseases
12/28/2005EP1608367A1 Pramipexole for reducing excessive food intake by children
12/28/2005EP1608366A1 Use of ritonavir for the treatment of unconjugated hyperbilirubinemia
12/28/2005EP1608365A1 Method for treating vascular hyperpermeable disease
1 ... 4419 4420 4421 4422 4423 4424 4425 4426 4427 4428 4429 4430 4431 4432 4433 4434 4435 4436 4437 4438 4439 ... 7860